Ufimep CL 500mg/500mg Injection

Overview Ufimep CL 500mg/500mg Injection

Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, targets serious bacterial infections. This medication combats infection-causing organisms to curb disease progression. Administration must be overseen by a medical professional. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions like redness, swelling, and pain may occur but usually subside. Severe or worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, itching, swelling, breathing difficulty). Inform your doctor of all current medications, including those for pre-existing conditions, before initiating treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur.

Primary Ingredients of Ufimep CL 500mg/500mg Injection

The provided text is "undefined," which cannot be rephrased while maintaining meaning and length. There is no text to rewrite.

Uses of Ufimep CL 500mg/500mg Injection

Life-threatening bacterial infestations

Major Benefits of Ufimep CL 500mg/500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Ufimep CL 500mg/500mg Injection:

• Nausea
• Vomiting
• Diarrhea
• Rash

How to use Ufimep CL 500mg/500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

How Ufimep CL 500mg/500mg Injection works:

The injectable formulation Ufimep CL, containing 500mg of each Imipenem and Cilastatin, utilizes a dual-drug approach. Imipenem, a potent antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Cilastatin, a dehydropeptidase I inhibitor, safeguards Imipenem from enzymatic degradation (specifically by dehydropeptidase I). This protective action prolongs Imipenem's therapeutic effectiveness within the patient.

What if you forget to take Ufimep CL 500mg/500mg Injection :

Should you inadvertently skip a scheduled dose of Ufimep CL 500mg/500mg Injection, seek medical advice from your physician.